References

  1. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 — 11 March 2020. March 11, 2020.
  2. World Health Organization. Coronavirus disease (COVID-19) outbreak. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.[Accessed: 03.05.2020]
  3. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020. MMWR Morb Mortal Wkly Rep. ePub: 31 March 2020.
  4. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA . 2020 [Epub ahead of print]
  5. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, Chinese Pediatric Novel Coronavirus Study Team, et al. SARS-CoV-2 infection in children.N Engl J Med . 2020. [Epub ahead of print]
  6. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics . 2020. [Epub ahead of print]
  7. Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China. JAMA Oncol.  March 25, 2020. [Epub ahead of print]
  8. Hrusak O, Kalina T, Wolf J, Balduzzi A, Provenzi M et al. Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment. Eur J Cancer . 2020;132:11-16.
  9. Sieni E, Pegoraro F, Casini T et al. Favourable outcome of Coronavirus-19 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression. Br J Haematol . 2020. [Epub ahead of print]
  10. D’Antiga L. Coronaviruses and immunosuppressed patients. The facts during the third epidemic. Liver Transpl . 2020. [Epub ahead of print]
  11. Filocamo G, Minoia F, Carbogno S et al. Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs. J Rheumatology . Apr 2020. [Epub ahead of print]
  12. Minotti C, Tirelli F, Barbieri E, Giaquinto C, Donà D. How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review. 2020 Apr 23. J Infect . 2020; S0163-4453(20)30237-1.
  13. Balduzzi, A., Brivio, E., Rovelli, A. et al.  Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote paratiBone Marrow Transplant . (2020). [Epub ahead of print]